Terms: = Skin cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712
44 results:
1. Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review.
Li C; Li K; Zhong S; Tang M; Shi X; Bao Y
Crit Rev Oncol Hematol; 2024 Feb; 194():104227. PubMed ID: 38220124
[TBL] [Abstract] [Full Text] [Related]
2. Multimodal imaging-based material mass density estimation for proton therapy using supervised deep learning.
Chang CW; Marants R; Gao Y; Goette M; Scholey JE; Bradley JD; Liu T; Zhou J; Sudhyadhom A; Yang X
Br J Radiol; 2023 Dec; 96(1152):20220907. PubMed ID: 37660372
[TBL] [Abstract] [Full Text] [Related]
3. Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis.
Jablonska PA; Muniz T; Ribeiro M; Liu ZA; Ye XY; Devaraja K; Laperriere N; Millar BA; Conrad T; Kongkham P; Butler M; Shultz DB
J Neurooncol; 2023 Aug; 164(1):199-209. PubMed ID: 37552363
[TBL] [Abstract] [Full Text] [Related]
4. Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung cancer, Melanoma, and Renal Cell Carcinoma Brain Metastases.
Lehrer EJ; Kowalchuk RO; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Harmsen WS; Jones BM; Sharma S; Ahluwalia MS; Sheehan JP; Trifiletti DM
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):858-868. PubMed ID: 36690161
[TBL] [Abstract] [Full Text] [Related]
5. Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients.
Lehrer EJ; Gurewitz J; Bernstein K; Kondziolka D; Fakhoury KR; Rusthoven CG; Niranjan A; Wei Z; Lunsford LD; Malouff TD; Ruiz-Garcia H; Peterson JL; Bonney P; Hwang L; Yu C; Zada G; Deibert CP; Prasad RN; Raval RR; Palmer JD; Patel S; Picozzi P; Franzini A; Attuati L; Mathieu D; Trudel C; Lee CC; Yang HC; Jones BM; Green S; Ahluwalia MS; Sheehan JP; Trifiletti DM
Neurosurgery; 2022 Dec; 91(6):872-882. PubMed ID: 36255215
[TBL] [Abstract] [Full Text] [Related]
6. Environmental/Occupational Exposure to Radon and Non-Pulmonary Neoplasm Risk: A Review of Epidemiologic Evidence.
Mozzoni P; Pinelli S; Corradi M; Ranzieri S; Cavallo D; Poli D
Int J Environ Res Public Health; 2021 Oct; 18(19):. PubMed ID: 34639764
[TBL] [Abstract] [Full Text] [Related]
7. Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location.
Choi S; Hong A; Wang T; Lo S; Chen B; Silva I; Kapoor R; Hsiao E; Fogarty GB; Carlino MS; Menzies AM; Long GV; Shivalingam BS
Strahlenther Onkol; 2021 Dec; 197(12):1104-1112. PubMed ID: 34114045
[TBL] [Abstract] [Full Text] [Related]
8.
Brimson JM; Prasanth MI; Malar DS; Brimson S; Tencomnao T
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33317106
[No Abstract] [Full Text] [Related]
9. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract] [Full Text] [Related]
10. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
[TBL] [Abstract] [Full Text] [Related]
11. The splicing factor u2af1 contributes to cancer progression through a noncanonical role in translation regulation.
Palangat M; Anastasakis DG; Fei DL; Lindblad KE; Bradley R; Hourigan CS; Hafner M; Larson DR
Genes Dev; 2019 May; 33(9-10):482-497. PubMed ID: 30842218
[TBL] [Abstract] [Full Text] [Related]
12. A Pilot Project to Investigate Radiation Therapist Referrals to an Ad Hoc Supportive Care Oncology Clinic.
Turner A; Nathoo D
J Med Imaging Radiat Sci; 2019 Mar; 50(1):12-16. PubMed ID: 30777233
[TBL] [Abstract] [Full Text] [Related]
13. Dermatology on YouTube - an update and analysis of new trends.
St Claire KM; Rietcheck HR; Patel RR; Dunnick C; Dellavalle RP
Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677792
[TBL] [Abstract] [Full Text] [Related]
14. [Recurrent nevus: Case-report about a pagetoid form occurring from a congenital nevus in infancy].
Bompy L; Levasseur J; Hallier A; Fraitag S; Aubriot-Lorton MH; Bonniaud B; Zwetyenga N
Ann Chir Plast Esthet; 2018 Jul; 63(4):349-352. PubMed ID: 29625761
[TBL] [Abstract] [Full Text] [Related]
15. Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects.
Diao K; Bian SX; Routman DM; Yu C; Kim PE; Wagle NA; Wong MK; Zada G; Chang EL
J Neurosurg; 2018 Dec; 129(6):1397-1406. PubMed ID: 29303446
[TBL] [Abstract] [Full Text] [Related]
16. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
[TBL] [Abstract] [Full Text] [Related]
17. Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.
Glitza IC; Guha-Thakurta N; D'Souza NM; Amaria RN; McGovern SL; Rao G; Li J
Melanoma Res; 2017 Dec; 27(6):580-584. PubMed ID: 28817446
[TBL] [Abstract] [Full Text] [Related]
18. Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
Kotecha R; Miller JA; Venur VA; Mohammadi AM; Chao ST; Suh JH; Barnett GH; Murphy ES; Funchain P; Yu JS; Vogelbaum MA; Angelov L; Ahluwalia MS
J Neurosurg; 2018 Jul; 129(1):50-59. PubMed ID: 28799876
[TBL] [Abstract] [Full Text] [Related]
19. Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).
Park J; Yang J; Wenzel AT; Ramachandran A; Lee WJ; Daniels JC; Kim J; Martinez-Escala E; Amankulor N; Pro B; Guitart J; Mendillo ML; Savas JN; Boggon TJ; Choi J
Blood; 2017 Sep; 130(12):1430-1440. PubMed ID: 28694326
[TBL] [Abstract] [Full Text] [Related]
20. Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.
Fang P; Jiang W; Allen P; Glitza I; Guha N; Hwu P; Ghia A; Phan J; Mahajan A; Tawbi H; Li J
J Neurooncol; 2017 Jul; 133(3):595-602. PubMed ID: 28500560
[TBL] [Abstract] [Full Text] [Related]
[Next]
